Abstract:Purpose Dopamine transporter (DAT) is a promising target for positron emission tomography (PET) imaging of many neuropsychiatric diseases. 18 F-labelled N-alkyl tropane analogues were reported to be useful PET radioligands for DAT. However, the drawback of 18 F-labelled tropane analogues is that N -alkyl on tropane is easily metabolized in vivo , which interferes with brain imaging. To develop a more in vivo stable DAT-targeted PET radioligand with high DAT affinity and specificity, in this study, we synthesized and compared a series of 18 F-labelled novel deuterated N-fluoropropyl tropane derivatives [ 18 F] 4a-e for DAT tracing. Procedures Five deuterated N-fluoropropyl-d 6 tropane derivatives ( 4a-e ) and corresponding non-deuterated compounds ( 6a-e ) were synthesized, and their semi-inhibitory concentrations (IC 50 ) were measured by competitive binding assay. The radioligands [ 18 F] 4a-e and [ 18 F] 6a-e were obtained by two-step one-pot radio-labelling reactions. The selectivity and specificity of these radioligands were evaluated by cellular uptake and microPET in normal rats. [ 18 F] 4e was selected for further investigation with microPET of the PD model, autoradiography and biodistribution experiments and compared with its non-deuterated [ 18 F] 6e . Finally, in vivo metabolic stability was analyzed by radio-HPLC. Results Ten tropane compounds had high DAT affinity (IC 50 = 2–21 nM), in which FP-CIT-d 6 ( 4e ) had the lowest IC 50 value of 2.7 nM. Radiolabelled [ 18 F] 4a-e and [ 18 F] 6a-e were obtained with radiochemical yields ranging from 10.6 ± 2.8% to 35.1 ± 5.4% with molar activities >20 GBq/μmol and the radiochemical purities >99%. [ 18 F] 4e showed the highest cell uptake (12%) and CFT inhibition efficacy (∼72%) among [ 18 F] 4a-e . MicroPET results showed [ 18 F] 4e has the highest target to non-target ratio (striatum/cerebellum). Therefore, [ 18 F] 4e was then selected for further biological evaluation. Ex vivo autoradiography experiment confirmed high specific binding of [ 18 F] 4e towards DAT. Biodistribution results indicated that [ 18 F] 4e has a higher striatum/cerebellum value than [ 18 F]FP-CIT ([ 18 F] 6e ) at 30–120 min. Furthermore, in vivo metabolism studies in rats revealed improved stability of [ 18 F] 4e as compared with that of [ 18 F] 6e . Conclusions The new probe [ 18 F] 4e is a promising candidate with good DAT affinity, specificity and metabolic stability for PET imaging, and might provide reliable diagnosis, treatment and prognostic detection of DAT-related neuropsychiatric diseases.

Characterization of Novel Pyrovalerone Analogs as Potential Dopamine Transporter Irreversible Ligands

Design, synthesis, and characterization of a novel, 4-[2-(diphenylmethoxy)ethyl]-1-benzyl piperidine-based, dopamine transporter photoaffinity label

Modifications to 1-(4-(2-Bis(4-fluorophenyl)methyl)sulfinyl)alkyl Alicyclic Amines That Improve Metabolic Stability and Retain an Atypical DAT Inhibitor Profile

Identification of Pyrimidine Structure-Based Compounds As Allosteric Ligands of the Dopamine Transporter As Therapeutic Agents for NeuroHIV.

Dopamine reuptake and inhibitory mechanisms in human dopamine transporter

The Pharmacological Profile of Second Generation Pyrovalerone Cathinones and Related Cathinone Derivative

Cryo-EM structure of the dopamine transporter with a novel atypical non-competitive inhibitor bound to the orthosteric site

Bivalent phenethylamines as novel dopamine transporter inhibitors: evidence for multiple substrate-binding sites in a single transporter

Expression and regulation of the human dopamine transporter in a neuronal cell line (vol 59, pg 66, 1998)

Investigation of cathinone analogs targeting human dopamine transporter using molecular modeling

Human dopamine transporter: the first implementation of a combined in silico/in vitro approach revealing the substrate and inhibitor specificities

Structural requirements for 2,4- and 3,6-disubstituted pyran biomimetics of cis-(6-benzhydryl-piperidin-3-yl)-benzylamine compounds to interact with monoamine transporters

Ligand Selectivity among the Dopamine and Serotonin Transporters Specified by the Forward Binding Reaction

Structure of the human dopamine transporter in complex with cocaine

Regulation of the dopamine transporter: aspects relevant to psychostimulant drugs of abuse

Synthesis and biological evaluation of 18 F-labelled deuterated tropane derivatives as dopamine transporter probes

Functional characterization of N-octyl 4-methylamphetamine variants and related bivalent compounds at the dopamine and serotonin transporters using Ca2+ channels as sensors

Dopaminergic Pharmacology Revealed by Structures of Human Dopamine D3 Receptor-G I Complexes

Substrate-induced Conformational Dynamics of the Dopamine Transporter

Structure of the human dopamine transporter and mechanisms of inhibition

Synthesis and initial evaluation of radioiodine-labelled deuterated tropane derivatives targeting dopamine transporter